Mei Mei Hu
Gründer bei VAXXINITY, INC.
Vermögen: 9 Mio $ am 30.04.2024
Aktive Positionen von Mei Mei Hu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VAXXINITY, INC. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Vorstandsvorsitzender | 01.01.2014 | - | |
Gründer | 01.01.2014 | - | |
Präsident | 01.01.2014 | - | |
UNITED BIOPHARMA INC | Direktor/Vorstandsmitglied | 01.03.2020 | - |
Covaxx, Inc.
Covaxx, Inc. BiotechnologyHealth Technology Covaxx, Inc. is a vaccine development company that focuses on creating vaccines for COVID-19, neurological disorders such as Alzheimer's and Parkinson's diseases, as well as prevalent chronic disorders like migraine and hypercholesterolemia. The private company is based in Dallas, TX, with operations in other locations. Covaxx recently consolidated with United Neuroscience to form a new holding company called Vaxxinity, Inc. Vaxxinity's lead candidate in its pipeline is UB-612, a vaccine candidate to fight SARS-CoV-2. Additionally, Vaxxinity has deployed hundreds of thousands of SARS-CoV-2 ELISA tests, which have received FDA emergency use authorization (EUA). The company was founded in 2020 by Peter H. Diamandis, and the CEO is Mei Mei Hu. | Vorstandsvorsitzender | 01.03.2020 | - |
Karriereverlauf von Mei Mei Hu
Ehemalige bekannte Positionen von Mei Mei Hu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shen Lian Biotechnology Co. Ltd. | Direktor/Vorstandsmitglied | 01.01.2010 | 01.01.2014 |
United Neuroscience LLC | Direktor/Vorstandsmitglied | 01.10.2014 | - |
Ausbildung von Mei Mei Hu
University of Pennsylvania | Undergraduate Degree |
Harvard Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Taiwan | 2 |
China | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Founder | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VAXXINITY, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
United BioPharma, Inc.
United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
Covaxx, Inc.
Covaxx, Inc. BiotechnologyHealth Technology Covaxx, Inc. is a vaccine development company that focuses on creating vaccines for COVID-19, neurological disorders such as Alzheimer's and Parkinson's diseases, as well as prevalent chronic disorders like migraine and hypercholesterolemia. The private company is based in Dallas, TX, with operations in other locations. Covaxx recently consolidated with United Neuroscience to form a new holding company called Vaxxinity, Inc. Vaxxinity's lead candidate in its pipeline is UB-612, a vaccine candidate to fight SARS-CoV-2. Additionally, Vaxxinity has deployed hundreds of thousands of SARS-CoV-2 ELISA tests, which have received FDA emergency use authorization (EUA). The company was founded in 2020 by Peter H. Diamandis, and the CEO is Mei Mei Hu. | Health Technology |
United Neuroscience LLC | |
Shen Lian Biotechnology Co. Ltd. |
- Börse
- Insiders
- Mei Mei Hu
- Erfahrung